Max Healthcare has approved a significant capital expenditure to expand bed capacity at its hospitals. The investments include adding 209 b...

Varun Beverages reported strong Q3 CY2026 revenue, profit and volume growth, but its shares fell as higher packaging costs weighed on margi...

Varun Beverages reported a contraction in gross and EBITDA margins during Q3 CY2026 despite strong revenue growth. The company's revenue fr...

On Thursday, Indian equities experienced a recovery, with Nifty closing above the 22,900 mark. Stocks such as Reliance Industries, Jio Plat...

Google stock fell more than 10% in after-hours trading after Alphabet missed third-quarter earnings and revenue estimates. Despite weaker a...

Microsoft has unveiled its impressive financial performance, reporting a revenue of $92.3 billion and profits soaring past $36.6 billion. T...

PVR INOX plans an ambitious expansion, targeting to unveil around 90 to 100 new screens in FY 2027 and 150 to 175 in FY 2028. With a focus ...

Microsoft shares popped more than five percent Wednesday afternoon after it reported better than expected revenue and profit, fueled by its...

Coca-Cola has reiterated its plans to explore a potential IPO for Hindustan Coca-Cola Holdings later this week. The company aims to finaliz...

Indian equities ended lower on Wednesday, primarily driven by selling in heavyweight stocks. Information technology and oil and gas shares ...

The multiplex operator aims to open 90-100 screens in FY27, followed by 150-175 in FY28. It has identified around 300 cities for SMART Cine...

Waaree Energies reported a 14.7% year-on-year profit decline to Rs 718.68 crore in Q2FY27, despite 23.9% revenue growth. Margin pressure pe...

Coca-Cola has lifted its annual profit forecast, driven by robust demand for a range of beverages, particularly zero-sugar options. The com...

L&T Q2 Results: Larsen & Toubro announced significant financial results for the quarter ended September 30, 2026. The company reported a 33...

Radico Khaitan’s net revenue rose 16.8% year on year to Rs 1,745.1 crore in Q2 FY27, while net profit jumped 66.1% to Rs 230.9 crore. Premi...

The company outperformed the market by 1.1 times in both chronic and acute therapies. Cardiac and anti-diabetes brands registered growth of...

Indian equity markets have faced a decline for four consecutive sessions, with the Nifty falling significantly. Various factors, including ...